Back to Results
First PageMeta Content
Pharmaceutical sciences / Pharmaceutical industry / Drug discovery / Clinical research / Canadian Institutes of Health Research / Health Canada / Centre for Drug Research and Development / Medical research / Drug development / Health / Pharmacology / Medicine


Document Date: 2009-11-27 16:31:17

Open Document

File Size: 270,04 KB

Share Result on Facebook

City

Vancouver / TORONTO / New York City / /

Company

Drug Development Inc. / Merck Frosst Canada Ltd. / IBM Canada / QLT Inc. / Fonds / Angiotech Pharmaceuticals Inc. / Global HIV Vaccine Enterprise / Canadian Institutes / /

Country

Canada / /

Currency

USD / /

/

Event

Employment Change / /

Facility

Montreal Neurological Institute / /

/

IndustryTerm

biotechnology / pharmaceutical industry / digital media sectors / financial and accounting services / technology validation / energy / /

MedicalCondition

HIV / tumour / pains / prostate cancer / /

Organization

CENTRE FOR COMMERCIALIZATION OF RESEARCH / Excellence Steering Committee / Network of Centres / Merck Frosst Canada Ltd. MOVING PROSTATE CANCER DRUGS INTO CLINICAL TRIALS PROSTATE CENTRE / Prostate Centre / federal government / Centre for Drug Research and Development / RISK FOR BIOTECH COMPANIES CENTRE FOR DRUG RESEARCH AND DEVELOPMENT / Waterloo Accelerator Centre / Montreal Neurological Institute / Medical Research Council / /

Person

Alain Beaudet / Martin Gleave / Natalie Dakers / Alan Bernstein / Mario Thomas / /

/

Position

Executive Director / President / model for commercializing university health research / President and CEO / Managing Director / Executive Director / academic and industrial worlds / As president / inaugural President / scientist and professor / /

Product

THRIVE / /

Technology

biotechnology / /

URL

www.nce-rce.gc.ca / /

SocialTag